Core Viewpoint - Tianyi Medical (301097.SZ) has received a medical device registration certificate from the National Medical Products Administration for its blood dialysis concentrate product, which enhances its product line and competitiveness in the market [1] Group 1: Product Details - The registered blood dialysis concentrate consists of two components: A concentrate (A liquid) and a connected dry powder (B powder) [1] - A liquid is composed of sodium chloride, potassium chloride, calcium chloride, magnesium chloride, acetic acid, and dialysis water, while B powder contains sodium bicarbonate [1] - This combination of A liquid and B powder leverages the advantages of both types of concentrates, catering to personalized clinical treatment needs [1] Group 2: Strategic Implications - The acquisition of the medical device registration certificate extends the company's product chain and enriches its product categories [1] - This development is expected to enhance the company's overall competitiveness in the healthcare market [1]
天益医疗(301097.SZ)子公司血液透析浓缩物取得产品注册证书